In support of these findings, we observed that HCC patients with lower levels of the Top35 LNDH have higher methylation levels in the promoter of these lncRNAs and increased levels of DNMT1, DNMT3A and DNMT3B expression than patients with higher levels of Top35 LNDH. Here, DNMT3A is linked to hepatocellular carcinoma.